(Q48195036)

9 February 2018

title

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. (English)

1 reference

9 February 2018

0 references

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

7

1 reference

9 February 2018

author name string

M Souvatzoglou

1

1 reference

9 February 2018

A L Grosu

2

1 reference

9 February 2018

B Röper

3

1 reference

9 February 2018

B J Krause

4

1 reference

9 February 2018

R Beck

5

1 reference

9 February 2018

G Reischl

6

1 reference

9 February 2018

H-J Machulla

8

1 reference

9 February 2018

H-J Wester

9

1 reference

9 February 2018

M Piert

10

1 reference

9 February 2018

publication date

20 April 2007

1 reference

9 February 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

9 February 2018

volume

34

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

1566-1575

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-007-0424-3

exact match

0 references

cites work

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0424-3

pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia

21 January 2018

1 reference

12 December 2020

Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

1 reference

12 December 2020

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

1 reference

12 December 2020

Oxygenation of locally advanced recurrent rectal cancer, soft tissue sarcoma and breast cancer

1 reference

12 December 2020

Standardised uptake values from PET/CT images: comparison with conventional attenuation-corrected PET.

1 reference

12 December 2020

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

12 December 2020

Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.

1 reference

12 December 2020

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

1 reference

12 December 2020

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

1 reference

12 December 2020

Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.

1 reference

12 December 2020

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

1 reference

12 December 2020

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

12 December 2020

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

1 reference

12 December 2020

Angiogenesis and cancer metastases: therapeutic approaches

1 reference

12 December 2020

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

1 reference

12 December 2020

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

12 December 2020

Positron emission tomography for radiation treatment planning

1 reference

12 December 2020

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation

1 reference

12 December 2020

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

1 reference

12 December 2020

Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.

1 reference

12 December 2020

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

12 December 2020

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations

1 reference

12 December 2020

Attenuation correction for a combined 3D PET/CT scanner

1 reference

12 December 2020

Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements

1 reference

12 December 2020

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

1 reference

12 December 2020

Microwave-assisted (radio)halogenation of nitroimidazole-based hypoxia markers

1 reference

12 December 2020

Nitroimidazoles and imaging hypoxia

1 reference

12 December 2020

Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma

1 reference

12 December 2020

PET and PET/CT studies of tumor tissue oxygenation.

1 reference

12 December 2020

Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications.

1 reference

12 December 2020

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

1 reference

12 December 2020

Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke

1 reference

12 December 2020

Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology

1 reference

12 December 2020

10.1007/S00259-007-0424-3

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17447061

1 reference

9 February 2018